高级检索
当前位置: 首页 > 详情页

Ethnic Differences in MicroRNA-375 Expression Level and DNA Methylation Status in Type 2 Diabetes of Han and Kazak Populations

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Endocrinol, Shihezi 832002, Xinjiang, Peoples R China [2]Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Metab, Shihezi 832002, Xinjiang, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan 430030, Peoples R China [4]Shihezi Univ, Sch Med, Shihezi 832002, Xinjiang, Peoples R China [5]Shihezi Univ, Sch Med, Affiliated Hosp 1, Cent Lab, Shihezi 832002, Xinjiang, Peoples R China
出处:
ISSN:

摘要:
Han population is six times as likely as Kazak population to present with type 2 diabetes mellitus (T2DM) in China. We hypothesize that differential expression and CpG methylation of miR-375 may be an ethnic-related factor that influences the incidence of T2DM. The expression level of miR-375 was examined using real-time PCR on Kazak and Han T2DM plasma samples. Furthermore, the methylation levels of CpG sites of miR-375 promoter were determined by MassARRAY Spectrometry in these samples. The relative expression levels of plasma miR-375 in Kazak T2DM samples are 1, and the relative expression levels of plasma miR-375 in Han T2DM samples are 3. The mean level of miR-375 methylation, calculated from the methylation levels of the CpG sites, was 8.47% for the Kazak T2DM group and 10.38% for the Han T2DM group. Further, five CpG units showed a statistically significant difference between Kazak and Han T2DM samples, and, among them, four were hypomethylated and only one CpG unit showed hypermethylation in Kazak T2DM samples. These findings indicate that the expression levels of plasma miR-375 and its CpG methylation in the promoter region are ethnically different, which may contribute to the different incidence of diabetes observed in Kazak and Han populations.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢 3 区 医学:研究与实验
JCR分区:
出版当年[2012]版:
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版]

第一作者:
第一作者单位: [1]Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Endocrinol, Shihezi 832002, Xinjiang, Peoples R China [2]Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Metab, Shihezi 832002, Xinjiang, Peoples R China
通讯作者:
通讯机构: [1]Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Endocrinol, Shihezi 832002, Xinjiang, Peoples R China [2]Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Metab, Shihezi 832002, Xinjiang, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:1 总访问量:411 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)